FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034852671> ?p ?o ?g. }

• W3034852671 endingPage "294" @default.
• W3034852671 startingPage "294" @default.
• W3034852671 abstract "Hepatitis C virus (HCV) infection with associated chronic liver diseases is a major health problem worldwide. Here, we designed hepatitis B virus (HBV) small surface antigen (sHBsAg) virus-like particles (VLPs) presenting different epitopes derived from the HCV E2 glycoprotein (residues 412–425, 434–446, 502–520, and 523–535 of isolate H77C). Epitopes were selected based on their amino acid sequence conservation and were previously reported as targets of HCV neutralizing antibodies. Chimeric VLPs obtained in the Leishmania tarentolae expression system, in combination with the adjuvant Addavax, were used to immunize mice. Although all VLPs induced strong humoral responses, only antibodies directed against HCV 412–425 and 523–535 epitopes were able to react with the native E1E2 glycoprotein complexes of different HCV genotypes in ELISA. Neutralization assays against genotype 1–6 cell culture infectious HCV (HCVcc), revealed that only VLPs carrying the 412–425 epitope induced efficient HCV cross-neutralizing antibodies, but with isolate specific variations in efficacy that could not necessarily be explained by differences in epitope sequences. In contrast, antibodies targeting 434–446, 502–520, and 523–535 epitopes were not neutralizing HCVcc, highlighting the importance of conformational antibodies for efficient virus neutralization. Thus, 412–425 remains the most promising linear E2 epitope for further bivalent, rationally designed vaccine research." @default.
• W3034852671 created "2020-06-19" @default.
• W3034852671 creator A5007462829 @default.
• W3034852671 creator A5014943080 @default.
• W3034852671 creator A5024587927 @default.
• W3034852671 creator A5028717694 @default.
• W3034852671 creator A5038234181 @default.
• W3034852671 creator A5054997742 @default.
• W3034852671 creator A5073835639 @default.
• W3034852671 creator A5079039702 @default.
• W3034852671 date "2020-06-10" @default.
• W3034852671 modified "2023-10-17" @default.
• W3034852671 title "Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency" @default.
• W3034852671 cites W104942536 @default.
• W3034852671 cites W1532585732 @default.
• W3034852671 cites W1581106319 @default.
• W3034852671 cites W1942705005 @default.
• W3034852671 cites W1976844675 @default.
• W3034852671 cites W1978916431 @default.
• W3034852671 cites W1988789252 @default.
• W3034852671 cites W1992275902 @default.
• W3034852671 cites W1993958512 @default.
• W3034852671 cites W1998738356 @default.
• W3034852671 cites W2001624137 @default.
• W3034852671 cites W2006538744 @default.
• W3034852671 cites W2015878390 @default.
• W3034852671 cites W2022687771 @default.
• W3034852671 cites W2028869643 @default.
• W3034852671 cites W2030371794 @default.
• W3034852671 cites W2037494007 @default.
• W3034852671 cites W2038281342 @default.
• W3034852671 cites W2043080047 @default.
• W3034852671 cites W2046182783 @default.
• W3034852671 cites W2047988967 @default.
• W3034852671 cites W2050671757 @default.
• W3034852671 cites W2053536599 @default.
• W3034852671 cites W2054730058 @default.
• W3034852671 cites W2064778609 @default.
• W3034852671 cites W2067909449 @default.
• W3034852671 cites W2072187355 @default.
• W3034852671 cites W2079204382 @default.
• W3034852671 cites W2085012067 @default.
• W3034852671 cites W2087813842 @default.
• W3034852671 cites W2092637586 @default.
• W3034852671 cites W2096347191 @default.
• W3034852671 cites W2102253058 @default.
• W3034852671 cites W2106118844 @default.
• W3034852671 cites W2111243299 @default.
• W3034852671 cites W2112024536 @default.
• W3034852671 cites W2113710797 @default.
• W3034852671 cites W2115917312 @default.
• W3034852671 cites W2122043154 @default.
• W3034852671 cites W2133036275 @default.
• W3034852671 cites W2146116501 @default.
• W3034852671 cites W2147126871 @default.
• W3034852671 cites W2147911068 @default.
• W3034852671 cites W2149913957 @default.
• W3034852671 cites W2150983148 @default.
• W3034852671 cites W2154624072 @default.
• W3034852671 cites W2160174559 @default.
• W3034852671 cites W2162909292 @default.
• W3034852671 cites W2167714763 @default.
• W3034852671 cites W2338267612 @default.
• W3034852671 cites W2414133006 @default.
• W3034852671 cites W2462414039 @default.
• W3034852671 cites W2520597593 @default.
• W3034852671 cites W2544261095 @default.
• W3034852671 cites W2545259858 @default.
• W3034852671 cites W2593608883 @default.
• W3034852671 cites W2614788581 @default.
• W3034852671 cites W2762048449 @default.
• W3034852671 cites W2784238948 @default.
• W3034852671 cites W2786448332 @default.
• W3034852671 cites W2789261270 @default.
• W3034852671 cites W2801531265 @default.
• W3034852671 cites W2806630981 @default.
• W3034852671 cites W2809256426 @default.
• W3034852671 cites W2809785330 @default.
• W3034852671 cites W2892297389 @default.
• W3034852671 cites W2942541802 @default.
• W3034852671 doi "https://doi.org/10.3390/vaccines8020294" @default.
• W3034852671 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7350033" @default.
• W3034852671 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32532076" @default.
• W3034852671 hasPublicationYear "2020" @default.
• W3034852671 type Work @default.
• W3034852671 sameAs 3034852671 @default.
• W3034852671 citedByCount "14" @default.
• W3034852671 countsByYear W30348526712021 @default.
• W3034852671 countsByYear W30348526712022 @default.
• W3034852671 countsByYear W30348526712023 @default.
• W3034852671 crossrefType "journal-article" @default.
• W3034852671 hasAuthorship W3034852671A5007462829 @default.
• W3034852671 hasAuthorship W3034852671A5014943080 @default.
• W3034852671 hasAuthorship W3034852671A5024587927 @default.
• W3034852671 hasAuthorship W3034852671A5028717694 @default.
• W3034852671 hasAuthorship W3034852671A5038234181 @default.
• W3034852671 hasAuthorship W3034852671A5054997742 @default.
• W3034852671 hasAuthorship W3034852671A5073835639 @default.

• next